Clinical Trials Logo

Pain Catastrophizing clinical trials

View clinical trials related to Pain Catastrophizing.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05950126 Recruiting - Clinical trials for Pain Catastrophizing

Maternal Pain Catastrophizing Score is Related With Children's Postoperative Circumcision Pain

Start date: April 1, 2022
Phase:
Study type: Observational

The aim of this study was to evaluate the relation of maternal pain catastrophizing score with child's who underwent circumcision postoperative pain. A cross-sectional study and this study was performed at the Samsun University, Samsun Training and Research Hospital, Samsun, Türkiye. The mothers were divided into low pain catastrophizing (Group 1) and high pain catastrophizing (Group 2) group. Children's postoperative pain intensity was measured using the visual analog scale (VAS) and a faces pain scale (FPS).

NCT ID: NCT05895383 Recruiting - Procedural Pain Clinical Trials

Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy

SANO-VAS
Start date: May 24, 2023
Phase: Phase 4
Study type: Interventional

This study is being done to see if nitrous oxide during vasectomy decreases pain and anxiety, and also assess whether patients have better satisfaction when they control their own level of nitrous oxide during the procedure. If we find that patients experience less pain or anxiety with nitrous oxide, it could be suggested that self-adjusted nitrous oxide (SANO) may be a useful tool for improving experience of care during vasectomy.

NCT ID: NCT05487183 Recruiting - Pain Clinical Trials

Test Retest Reliability of OA and OH

Start date: August 5, 2022
Phase: N/A
Study type: Interventional

The goal of this study is to measure the test retest reliability of offset analgesia (OA) and onset hyperalgesia (OH) across multiple study visits. OA and OH are quantitative sensory tests (QST) thought to measure how the brain modulates pain. This study will use a heat thermode to induce OA and OH in healthy, pain-free volunteers across 3 study visits. Additional QST measures and survey data relevant to pain modulation will be collected. This study lays the foundation required to use OA and OH as tools to measure pain modulation in clinical trials. Following their validation, we anticipate that OA and OH will serve as predictive and therapeutic biomarkers, which will aid both in the development of novel analgesics and in treatment selection leading to the personalization of pain management.